Filing Details

Accession Number:
0001225208-11-024203
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-02 17:01:42
Reporting Period:
2011-11-01
Filing Date:
2011-11-02
Accepted Time:
2011-11-02 17:01:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Neoprobe Corp NEOP Surgical & Medical Instruments & Apparatus (3841) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1195766 L Brent Larson 425 Metro Place North
Suite 300
Dublin OH 43017
Svp, Cfo, Treas & Secy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-01 50,000 $0.42 204,912 No 4 M Direct
Common Stock Acquisiton 2011-11-01 40,000 $0.14 244,912 No 4 M Direct
Common Stock Acquisiton 2011-11-01 30,000 $0.13 274,912 No 4 M Direct
Common Stock Disposition 2011-11-01 12,500 $2.75 262,412 No 4 S Direct
Common Stock Disposition 2011-11-01 41,824 $2.84 220,588 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 50,000 $0.00 50,000 $0.42
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 40,000 $0.00 40,000 $0.14
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 30,000 $0.00 30,000 $0.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-01-07 No 4 M Direct
0 2013-01-15 No 4 M Direct
0 2013-02-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 95,869 Indirect By 401(k)
Footnotes
  1. The sales in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Larson on September 14, 2011.
  2. Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.71 to $2.79. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.
  3. Shares withheld by the Issuer in payment of the option exercise price and to satisfy tax withholding obligations.
  4. Option vests 1/3 of the underlying shares annually beginning on the first anniversary of the date of grant.